Correction to “Stem Cell-Derived Exosomes as Nanotherapeutics for Inflammatory Diseases”

doi:10.1002/mef2.70067

MEDCOMM - Future Medicine ›› 2026, Vol. 5 ›› Issue (3) :e70067 DOI: 10.1002/mef2.70067

CORRECTION

Correction to “Stem Cell-Derived Exosomes as Nanotherapeutics for Inflammatory Diseases”

Author information +

History +

PDF (198KB)

Cite this article

Download citation ▾

null. Correction to “Stem Cell-Derived Exosomes as Nanotherapeutics for Inflammatory Diseases”. MEDCOMM - Future Medicine, 2026, 5 (3) : e70067 DOI:10.1002/mef2.70067

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

Rights & permissions

2026 The Author(s). MedComm – Future Medicine published by John Wiley & Sons Australia, Ltd on behalf of Sichuan International Medical Exchange & Promotion Association (SCIMEA).